Shaun Larkin

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.

Vernalis Group, Inc. provides custom software and tech solutions.

Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK.

Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.

Virgin Health Bank Ltd. provides umbilical cord blood stem cell banking services. It offers family banking and community banking. The company was founded in 2009 and is headquartered in London, the United Kingdom.

Avena Therapeutics Ltd. is a private company headquartered in Dublin, Ireland, that engages in research and experimental development on natural sciences and engineering.

Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom.

Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia.

Rex Bionics Pty Ltd. manufactures hands-free robotic devices for rehabilitation. The company was founded in 2014 and is headquartered in Melbourne, Australia.

Smart Matrix Ltd. engages in the research and development of medical solutions. It focuses on commercializing its propriety platform technology Smart Matrix, a medical device that acts as a scaffold to assist wound healing. The company was founded in 2011 and is headquartered in London, the United Kingdom.

Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON.

Datacom Group Ltd. designs and builds information technology systems. It offers business process, customer engagement, financial and consulting services. The company was founded by Paul Hargreaves in 1965 is headquartered in Wellington, New Zealand.

Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia.

The SAVO Group Ltd. provides sales enablement software solutions. The firm offers financial, life sciences, technology and manufacturing solutions. It also offers smarter content, execution, engagement products. The company was founded by John Aiello and Drew Larsen in 1999 and is headquartered in Chicago, IL.

Agility CIS Ltd. engages in the provision of billing and customer management solutions to the utility sector. Its solutions include Engage, EngageCRM, EngageCSS, EngageX, EngageBI, and Ignite. The company was founded in 1998 and is headquartered in Ellerslie, New Zeland.

Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy.

Part of Avetta LLC, Pegasus Management Pty Ltd. is an Australian company that provides worker competency management software and services. The company is based in Newcastle, Australia. The company was founded in 1987. Adam Boyle has been the CEO of the company since 2007. Pegasus Management was acquired by Avetta LLC on July 19, 2021.

ABB Power Grids Australia Pty Ltd. provides enterprise asset management solutions for asset intensive industries such as energy, mining, public infrastructure, and transportation. It offers asset management, mobile workforce management, energy trading and risk management, and energy operations and energy analytics. The company was founded on June 19, 1979 and is headquartered in Brisbane, Australia.

Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany

The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom.

EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada.

Part of Shell Plc, Shell Capital, Inc. is a company based in Houston, TX.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.